Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD

E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland)

Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Session: COPD: novel pathological mechanisms in the airway epithelium
Session type: Thematic Poster
Number: 4271
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakiulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blassi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastrict, Netherlands), A. Lacoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), D. Stolz (Basel, Switzerland). Extracellular matrix glycosaminoglycans can predict severity and outcome in COPD. 4271

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Extracellular matrix remodelling in COPD
Source: Eur Respir Rev, 29 (158) 190124; 10.1183/16000617.0124-2019
Year: 2020



Extracellular matrix biomarkers predict change in lung function in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010


Extracellular matrix composition in COPD
Source: Eur Respir J 2012; 40: 1362-1373
Year: 2012



Role of matrix metalloproteinase in predicting of COPD stability
Source: International Congress 2015 – COPD: notable points
Year: 2015


Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity?
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Correlations of collagen matrix between nonspecific interstitial pneumonia and collagen disease - preliminary study
Source: Eur Respir J 2005; 26: Suppl. 49, 542s
Year: 2005

The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease
Source: Eur Respir J, 50 (1) 1601805; 10.1183/13993003.01805-2016
Year: 2017



Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

Extracellular matrix profile of lung in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011

Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Increased concentration of matrix metalloproteinase-9 in serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Collagen and elastin turnover increase at COPD exacerbation irrespectively its etiology
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Extracellular ATP as a biomarker of severity of chronic obstructive pulmonary disease
Source: International Congress 2019 – Injury and repair: less is more
Year: 2019




Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Sputum matrix metalloproteinase-9 and tissue inhibitor of matrix metalloprotienase-1 levels in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006

LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity
Source: Eur Respir J 2012; 39: 1475-1481
Year: 2012